Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

247 Episodo

  1. Memantine: Potential Indications in Youth

    Publicado: 22/4/2023
  2. Low-Dose Olanzapine for Anorexia Nervosa

    Publicado: 17/4/2023
  3. Naltrexone in Youth: Exploring Potential Applications and Cautions

    Publicado: 12/4/2023
  4. Lamotrigine Titration: Slowing Down for Safer Treatment

    Publicado: 7/4/2023
  5. Using Benzodiazepines in Geriatric Patients

    Publicado: 2/4/2023
  6. Lithium Use in Pediatric Patients

    Publicado: 28/3/2023
  7. Using Mood Stabilizers in the Geriatric Population

    Publicado: 23/3/2023
  8. Bright Light Therapy for Perinatal Depression

    Publicado: 18/3/2023
  9. Using SSRIs in the Geriatric Population

    Publicado: 13/3/2023
  10. Safety and Efficacy of Duloxetine in Youth With MDD

    Publicado: 8/3/2023
  11. Challenges in Prescribing Psychotropics to the Geriatric Population

    Publicado: 3/3/2023
  12. Antidepressants and Vertebral and Hip Risk Fractures

    Publicado: 26/2/2023
  13. Antidepressants and Mood Stabilizers for Managing Explosive Behavior

    Publicado: 21/2/2023
  14. Risk of Substance Use Disorders in Children Treated With Psychotropics

    Publicado: 16/2/2023
  15. FGAs and SGAs for Managing Explosive Behavior

    Publicado: 11/2/2023
  16. Use of Metformin to Prevent Clozapine-Induced Weight Gain

    Publicado: 6/2/2023
  17. Managing Acute Aggression in Children and Adolescents

    Publicado: 1/2/2023
  18. Early Antipsychotic Nonresponse as a Predictor of Nonresponse

    Publicado: 27/1/2023
  19. Differential Diagnosis of Explosive Behavior

    Publicado: 22/1/2023
  20. Long-Term Follow-Up of Schizophrenia in Youth

    Publicado: 17/1/2023

7 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site